Multi-omic analysis reveals metabolic pathways that characterize right-sided colon cancer liver metastasis
Cancer Letters · 2023
DOI: 10.1016/j.canlet.2023.216384 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Letters, 2023. Verfasst von Montana T Morris und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery/Surgical Oncology, Yale School of Medicine, 333 Cedar Street, New Haven, CT, 06510, USA. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Colonic Neoplasms, Liver Neoplasms, Kidney Neoplasms. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
There are well demonstrated differences in tumor cell metabolism between right sided (RCC) and left sided (LCC) colon cancer, which could underlie the robust differences observed in their clinical behavior, particularly in metastatic disease. As such, we utilized liquid chromatography-mass spectrometry to perform an untargeted metabolomics analysis comparing frozen liver metastasis (LM) biobank samples derived from patients with RCC (N = 32) and LCC (N = 58) to further elucidate the unique biology of each. We also performed an untargeted RNA-seq and subsequent network analysis on samples derived from an overlapping subset of patients (RCC: N = 10; LCC: N = 18). Our biobank redemonstrates the inferior survival of patients with RCC-derived LM (P = 0.04), a well-established finding. Our metabolomic results demonstrate increased reactive oxygen species associated metabolites and bile acids in RCC. Conversely, carnitines, indicators of fatty acid oxidation, are relatively increased in LCC. The transcriptomic analysis implicates increased MEK-ERK, PI3K-AKT and Transcription Growth Factor Beta signaling in RCC LM. Our multi-omic analysis reveals several key differences in cellular physiology which taken together may be relevant to clinical differences in tumor behavior between RCC and LCC liver metastasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgery/Surgical Oncology, Yale School of Medicine, 333 Cedar Street, New Haven, CT, 06510, USA.
- Department of Environmental Health Sciences, Yale School of Public Health, 60 College Street, New Haven, CT, 06510, USA.
- Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY, 10065, USA.
- Department of Medicine/Gastroenterology, Duke University School of Medicine, 124 Davison Building, Durham, NC, 27710, USA.
- Department of Genetics, Yale School of Medicine, 333 Cedar Street, New Haven, CT, 06378, USA.
- Department of Environmental Health Sciences, Yale School of Public Health, 60 College Street, New Haven, CT, 06510, USA. Electronic address: caroline.johnson@yale.edu.
Förderung
- NCATS NIH HHS
- NCI NIH HHS
Zitieren
APA
Morris, M. T., Jain, A., Sun, B., Kurbatov, V., Muca, E., Zeng, Z., Jin, Y., Roper, J., Lu, J., Paty, P. B., Johnson, C. H., & Khan, S. A. (2023). Multi-omic analysis reveals metabolic pathways that characterize right-sided colon cancer liver metastasis. Cancer Letters. https://doi.org/10.1016/j.canlet.2023.216384
Vancouver
Morris MT, Jain A, Sun B, Kurbatov V, Muca E, Zeng Z, et al. Multi-omic analysis reveals metabolic pathways that characterize right-sided colon cancer liver metastasis. Cancer Letters. 2023. doi:10.1016/j.canlet.2023.216384
BibTeX
@article{Morris2023,
author = {Morris, Montana T and Jain, Abhishek and Sun, Boshi and Kurbatov, Vadim and Muca, Engjel and Zeng, Zhaoshi and Jin, Ying and Roper, Jatin and Lu, Jun and Paty, Philip B and Johnson, Caroline H and Khan, Sajid A},
title = {Multi-omic analysis reveals metabolic pathways that characterize right-sided colon cancer liver metastasis},
journal = {Cancer Letters},
year = {2023},
doi = {10.1016/j.canlet.2023.216384}
}
EUVIMED